Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CRESEMBA 186 MG CAPSULE

isavuconazonium sulfate
$114.1170per EA

Strength

100 mg/1

Manufacturer

Astellas Pharma US, Inc.

NDC

00469052002

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

1/14/2026

Active Ingredients

ISAVUCONAZONIUM SULFATE

Approval Type

New Drug (NDA)

FDA Application

NDA207500

On Market Since

11/4/2015

Pharmacological Classes

Azole Antifungal
Azoles
Cytochrome P450 3A4 Inhibitors
Organic Cation Transporter 2 Inhibitors
P-Glycoprotein Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+2.6%

3Y

+11.9%

5Y

N/A

All

+17.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

LOTRIMIN AF 2% POWDER
Brand
11523091901•Bayer HealthCare LLC
$0.0487
per GM
REMEDY ANTIFUNGAL 2% CREAM
Brand
53329016204•Medline Industries, LP
$0.0489
per ML
MICRO-GUARD 2% POWDER
Brand
11701003816•Coloplast Manufacturing US, LLC
$0.0573
per GM
VANDAZOLE VAGINAL 0.75% GEL
Brand
00245086070•Upsher-Smith Laboratories LLC
$0.3451
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096301•Bayer HealthCare LLC
$0.3549
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096307•Bayer HealthCare LLC
$0.3549
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096305•Bayer HealthCare LLC
$0.5097
per GM
FUNGOID 2% TINCTURE
Brand
00884029301•Pedinol Pharmacal, Inc.
$0.5848
per ML
TIAZAC ER 180 MG CAPSULE
Brand
00187261330•Bausch Health US LLC
$1.5060
per EA
TIAZAC ER 180 MG CAPSULE
Brand
00187261390•Bausch Health US LLC
$1.5060
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy